AxoGen Future Growth
Future criteria checks 4/6
AxoGen is forecast to grow earnings and revenue by 97.1% and 11.6% per annum respectively while EPS is expected to grow by 72.2% per annum.
Key information
97.1%
Earnings growth rate
72.2%
EPS growth rate
Medical Equipment earnings growth | 16.7% |
Revenue growth rate | 11.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 30 May 2024 |
Recent future growth updates
Recent updates
Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 27% Share Price Boost
Jun 12Is AxoGen (NASDAQ:AXGN) Using Too Much Debt?
Apr 16Positive Sentiment Still Eludes AxoGen, Inc. (NASDAQ:AXGN) Following 26% Share Price Slump
Mar 28Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 33% Share Price Boost
Jan 26We Think AxoGen (NASDAQ:AXGN) Has A Fair Chunk Of Debt
Sep 10Market Cool On AxoGen, Inc.'s (NASDAQ:AXGN) Revenues
Aug 09AxoGen (NASDAQ:AXGN) Has Debt But No Earnings; Should You Worry?
Jan 13Is AxoGen (NASDAQ:AXGN) A Risky Investment?
Sep 10AxoGen: Investors Are Positioned Long Leading Into Q2 FY22 Earnings
Aug 02Axogen estimates Q2 revenue above consensus, reaffirms guidance
Jul 18Health Check: How Prudently Does AxoGen (NASDAQ:AXGN) Use Debt?
May 04Axogen Needs RECON More Than Ever To Recharge The Bull Case
Mar 08Is AxoGen (NASDAQ:AXGN) Using Debt Sensibly?
Dec 15Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 224 | 26 | 25 | N/A | 2 |
12/31/2025 | 201 | 6 | 14 | N/A | 5 |
12/31/2024 | 179 | -18 | -9 | N/A | 5 |
3/31/2024 | 164 | -21 | -22 | -11 | N/A |
12/31/2023 | 159 | -22 | -21 | -6 | N/A |
9/30/2023 | 152 | -23 | -24 | -4 | N/A |
6/30/2023 | 148 | -23 | -27 | -6 | N/A |
3/31/2023 | 144 | -25 | -33 | -12 | N/A |
12/31/2022 | 139 | -29 | -37 | -16 | N/A |
9/30/2022 | 134 | -29 | -41 | -19 | N/A |
6/30/2022 | 128 | -32 | -45 | -19 | N/A |
3/31/2022 | 127 | -32 | -44 | -14 | N/A |
12/31/2021 | 127 | -27 | -42 | -13 | N/A |
9/30/2021 | 128 | -28 | -34 | -9 | N/A |
6/30/2021 | 131 | -22 | -27 | -6 | N/A |
3/31/2021 | 119 | -22 | -33 | -12 | N/A |
12/31/2020 | 112 | -24 | -32 | -10 | N/A |
9/30/2020 | 108 | -25 | -36 | -16 | N/A |
6/30/2020 | 103 | -29 | -37 | -20 | N/A |
3/31/2020 | 108 | -28 | -29 | -19 | N/A |
12/31/2019 | 107 | -29 | -25 | -20 | N/A |
9/30/2019 | 102 | -27 | -26 | -22 | N/A |
6/30/2019 | 96 | -26 | -30 | -23 | N/A |
3/31/2019 | 90 | -26 | -27 | -21 | N/A |
12/31/2018 | 84 | -22 | -24 | -18 | N/A |
9/30/2018 | 77 | -20 | -21 | -14 | N/A |
6/30/2018 | 71 | -18 | -15 | -13 | N/A |
3/31/2018 | 65 | -12 | -13 | -11 | N/A |
12/31/2017 | 60 | -10 | N/A | -9 | N/A |
9/30/2017 | 55 | -14 | N/A | -10 | N/A |
6/30/2017 | 50 | -14 | N/A | -10 | N/A |
3/31/2017 | 45 | -14 | N/A | -11 | N/A |
12/31/2016 | 41 | -14 | N/A | -11 | N/A |
9/30/2016 | 38 | -12 | N/A | -14 | N/A |
6/30/2016 | 34 | -13 | N/A | -14 | N/A |
3/31/2016 | 30 | -13 | N/A | -15 | N/A |
12/31/2015 | 27 | -13 | N/A | -13 | N/A |
9/30/2015 | 24 | -16 | N/A | -11 | N/A |
6/30/2015 | 21 | -16 | N/A | -11 | N/A |
3/31/2015 | 19 | -17 | N/A | -10 | N/A |
12/31/2014 | 17 | -18 | N/A | -10 | N/A |
9/30/2014 | 15 | -15 | N/A | -10 | N/A |
6/30/2014 | 13 | -16 | N/A | -11 | N/A |
3/31/2014 | 12 | -15 | N/A | -11 | N/A |
12/31/2013 | 11 | -15 | N/A | -10 | N/A |
9/30/2013 | 10 | -14 | N/A | -11 | N/A |
6/30/2013 | 9 | -13 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AXGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: AXGN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AXGN is expected to become profitable in the next 3 years.
Revenue vs Market: AXGN's revenue (11.6% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: AXGN's revenue (11.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AXGN's Return on Equity is forecast to be high in 3 years time